IRIS
POLONELLI, Luciano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.357
AS - Asia 11.693
EU - Europa 10.369
SA - Sud America 3.084
AF - Africa 744
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 7
Totale 39.273
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.837
SG - Singapore 4.692
CN - Cina 3.918
BR - Brasile 2.459
UA - Ucraina 2.120
IE - Irlanda 1.808
DE - Germania 1.631
VN - Vietnam 1.271
SE - Svezia 1.224
FI - Finlandia 1.183
IT - Italia 919
HK - Hong Kong 891
ZA - Sudafrica 555
NL - Olanda 545
CA - Canada 391
RU - Federazione Russa 279
AR - Argentina 268
TR - Turchia 225
GB - Regno Unito 185
AT - Austria 134
EC - Ecuador 126
IN - India 117
FR - Francia 104
BD - Bangladesh 98
IQ - Iraq 91
MX - Messico 79
ID - Indonesia 75
JP - Giappone 56
CO - Colombia 50
PY - Paraguay 49
MA - Marocco 45
BE - Belgio 44
PK - Pakistan 43
PL - Polonia 40
VE - Venezuela 38
CL - Cile 36
ES - Italia 32
KE - Kenya 32
EG - Egitto 29
UZ - Uzbekistan 27
PE - Perù 24
TN - Tunisia 22
AE - Emirati Arabi Uniti 21
UY - Uruguay 20
SA - Arabia Saudita 17
AZ - Azerbaigian 16
IL - Israele 16
EU - Europa 15
NP - Nepal 15
CZ - Repubblica Ceca 14
JO - Giordania 14
BG - Bulgaria 13
KZ - Kazakistan 13
LB - Libano 12
LT - Lituania 12
BO - Bolivia 11
RO - Romania 11
AL - Albania 10
DO - Repubblica Dominicana 10
DZ - Algeria 10
CI - Costa d'Avorio 9
CR - Costa Rica 8
HU - Ungheria 8
RS - Serbia 8
BH - Bahrain 7
BY - Bielorussia 7
NG - Nigeria 6
OM - Oman 6
PA - Panama 6
PS - Palestinian Territory 6
AO - Angola 5
BA - Bosnia-Erzegovina 5
HN - Honduras 5
HR - Croazia 5
KR - Corea 5
LK - Sri Lanka 5
MY - Malesia 5
SY - Repubblica araba siriana 5
AU - Australia 4
BW - Botswana 4
ET - Etiopia 4
GE - Georgia 4
JM - Giamaica 4
KG - Kirghizistan 4
KW - Kuwait 4
LU - Lussemburgo 4
NI - Nicaragua 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
BB - Barbados 3
CH - Svizzera 3
EE - Estonia 3
GA - Gabon 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
TG - Togo 3
ZW - Zimbabwe 3
CG - Congo 2
Totale 39.231
Salva come PNG Salva come JPEG
Città #
Jacksonville 2.243
Singapore 2.088
Dublin 1.806
Chandler 1.158
Ashburn 1.070
Beijing 1.047
Hong Kong 883
Dearborn 780
Nanjing 646
Boardman 609
Santa Clara 587
San Mateo 570
Dallas 538
Johannesburg 511
Ho Chi Minh City 507
Princeton 504
Toronto 320
Des Moines 264
Ann Arbor 245
Bremen 243
Hanoi 238
Moscow 220
Helsinki 216
Wilmington 216
Shenyang 191
São Paulo 191
Izmir 182
Munich 180
Kunming 171
Nanchang 167
Hefei 162
Hebei 160
Los Angeles 159
New York 151
Parma 140
Vienna 125
Shanghai 122
Buffalo 112
Jinan 105
Düsseldorf 103
Grafing 101
Tianjin 91
Changsha 83
Jiaxing 74
Rio de Janeiro 72
Guangzhou 67
Seattle 62
Fremont 61
Brasília 56
Haiphong 54
Quito 52
Woodbridge 52
Houston 47
Marseille 47
Da Nang 46
Curitiba 44
Brussels 42
Turku 42
Columbus 40
Porto Alegre 38
Norwalk 36
Milan 35
Biên Hòa 34
Belo Horizonte 33
Brooklyn 33
Salvador 33
Hangzhou 31
Tokyo 31
Baghdad 28
Guayaquil 28
Hải Dương 28
Warsaw 28
Nairobi 27
Rome 27
Zhengzhou 27
Campinas 26
Council Bluffs 26
Chennai 24
San Francisco 24
Thái Bình 24
Buenos Aires 23
Chicago 23
London 23
Tashkent 23
Borås 22
Frankfurt am Main 22
Manaus 22
Montreal 22
Orem 22
Chengdu 21
Atlanta 20
Bắc Ninh 20
Fortaleza 20
Jakarta 20
Redondo Beach 20
The Dalles 20
Wuhan 20
Asunción 19
Caxias do Sul 19
Osasco 19
Totale 22.104
Salva come PNG Salva come JPEG
Nome #
A transphyletic anti-infectious control strategy based on the killer phenomenon. 254
Il problema dell’antibiogramma nelle infezioni da funghi filamentosi. 184
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 179
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 177
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 170
Antibiocorpi: Anticorpi anti-idiotipo ad attività antibiotica in vivo ed in vitro 163
Antibodies as a source of anti-infective peptides: an update 163
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 158
Micologia Clinica. Manuale di Laboratorio. 154
L’antibiogramma per i miceti 151
Peptides of the Constant Region of Antibodies Display Fungicidal Activity 150
Antifungal peptides within the antibodies 150
A synthetic peptide as a novel anticryptococcal agent 149
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 147
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 147
Metabolic profiling of Candida albicans 145
Caratterizzazione ed isotipizzazione di anticorpi monoclonali murini anti-laminarina con potenziale attività candidacida. 145
Fungicidal activity of peptides encoded by immunoglobulin genes 144
Effect of different wavelengths and dyes on Candida albicans: In vivo study using Galleria mellonella as an experimental model 143
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 143
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 141
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BY DIFFERENT COUPLING OF WAVELENGTHS AND COLORS IN PHOTODYNAMIC PROTOCOLS: IN VITRO AND IN VIVO STUDY 139
Antifungal activity of the C-terminal peptide from human serum albumin 136
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 136
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 134
Anaerobic yeast killer system. 132
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 132
Antibody peptide based antifungal immunotherapy 131
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 131
Peptides from the inside of the antibodies are active against infectious agents and tumours 131
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 129
Antibody-mediated protective immunity in fungal infections 129
Natural and synthetic peptides with antifungal activity 128
Oral and maxillofacial fungal infections 128
Antibiocorpi: anticorpi anti-idiotipo ad attività antibiotica 127
A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities 127
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 127
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 126
Conformation-sensitive Antibodies against Alzheimer Amyloid-beta by Immunization with a Thioredoxin-constrained B-cell Epitope Peptide 123
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 123
Anticorpi immagini interne di tossine killer 122
AC-1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model 121
"Antibiobodies": yeast killer toxin-like anti-idiotypic antibodies 121
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. 120
Significato diagnostico di IgA secretorie adese a cellule lievitiformi nelle candidosi orali 119
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 118
Significato diagnostico delle IgA (secretorie) adese a miceti lievitiformi nel corso delle infezioni orali di pazienti a rischio. 118
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 118
A Multicenter Comparative Evaluation of Six Commercial Systems and the National Committee for Clinical Laboratory Standards M27-A Broth Microdilution Method for Fluconazole Susceptibility Testing of Candida Species 116
Antireceptor yeast killer toxin-like antibiobodies 115
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 115
Anticorpi antiidiotipici ricombinanti ad attività terapeutica fungicida. 114
Activity of nitroimidazole derivative synthetic compounds on Trichomonas vaginalis and Candida albicans isolates 113
Antibiobodies: antibiotic-like antiidiotypic antibodies. 113
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 112
A case of disseminated fatal infection caused by Nocardia caviae. 111
A multicenter study of the in vitro activity of voriconazole against 1,996 yeast and 192 mould clinical isolates 111
Antibiobodies: antibiotic internal image antibodies 111
Valutazione del sistema Bactec Mycobacterial Growth Indicator Tube (MGIT) 960 per il rilevamento di micobatteri dai materiali patologici in comparazione ai metodi radiometrico e tradizionale 111
Cases of imported malaria in Parma observed in the period January-September 1994 111
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 111
Chimeric symbionts expressing a Wolbachia protein stimulate mosquito immunity and inhibit filarial parasite development 111
Caratterizzazione dell'epitopo polisaccaridico reattivo con IgA secretorie della mannoproteina maggiore da stress secreta da Candida albicans. 110
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 109
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 109
A microautomated dilution method for susceptibility testing with antifungal drugs. 109
Mode of action of a killer peptide against Toxoplasma gondii 109
Innate antimicrobial and antiviral activities of antibody peptides 108
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 108
In vitro and in vivo anticandidal activity of killer peptide derivatives 107
Anti-idiotypic vaccination against group B streptococci 106
In vitro activity of killer peptide against Toxoplasma gondii tachyzoites 105
Metabolic profile of Candida albicans 104
Involvement of beta-glucans in the wide-spectrum antimicrobial activity of Williopsis saturnus var. mrakii MUCL 41968 killer toxin 104
Actinomiceti. 104
A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivo 102
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 101
Antibodies as Crypts of Antiinfective and Antitumor Peptides 100
In vitro tests: how do they influence therapeutic choices? 99
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 99
Marcatori epidemiologici. 99
Antibiotic antibodies 99
Clonaggio e sequenziamento dei geni codificanti per la tossina killer di Pichia anomala 98
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 97
Caratterizzazione antigenica di Microsporum canis, M. distortum, M. ferrugineum e Trichophyton soudanense. 97
Restriction of Influenza virus multiplication induced by PK peptide treatment 97
Development of a novel paratransgenic symbiotic-based control strategy for vector-borne infectious diseases 97
Inhibition performed by a synthetic microbicidal peptide on the replication of Influenza virus. Abstract 21.009 96
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 95
A Wickerhamomyces anomalus killer strain in the malaria vector Anopheles stephensi 95
Immagine interna del fenomeno killer dei lieviti 94
Yeast killer toxins and dimorphism. 94
In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus. 94
A novel glyco-conjugate vaccine against fungal pathogens 93
Identificazione di lieviti produttori di tossine killer in vivo 93
Biotipizzazione di microorganismi patogeni mediante il sistema killer dei lieviti. 93
Any antibody fragment might exert antifungal activity 93
Protective antifungal yeast killer toxin-like antibodies 92
Antifungal and antitumor activities of a monoclonal antibody directed against a stress mannoprotein of Candida albicans 92
Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies. 92
Totale 12.151
Salva come PNG Salva come JPEG
Categoria #
all - tutte 141.832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 141.832
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.651 0 0 0 0 0 32 456 19 581 40 502 21
2021/20222.384 23 6 7 50 83 111 333 458 97 285 95 836
2022/20235.790 940 414 267 308 585 607 48 289 2.149 20 111 52
2023/20241.866 105 189 65 53 189 511 50 100 20 133 167 284
2024/20256.781 43 565 563 307 587 571 107 210 1.281 855 464 1.228
2025/202610.084 1.128 1.804 2.195 2.316 2.308 333 0 0 0 0 0 0
Totale 39.435